Taiwan’s indigenously developed Medigen COVID-19 vaccine is as effective in preventing deaths and serious symptoms as mRNA shots, a study to be published in the US Centers for Disease Control and Prevention’s journal next month showed.
An early release of the study is available on the Web site of the Emerging Infectious Diseases journal.
The study, conducted by the Centers for Disease and Control (CDC), utilized data from Taiwan’s records of inoculations, hospitalizations and deaths since the local outbreak of the Omicron variant of SARS-CoV-2 in 2022.
Photo: Taipei Times
CDC Deputy Director-General Philip Lo (羅一鈞) said that the protein subunit-based Medigen vaccine had an effectiveness of 91 percent after three jabs.
The mRNA-based BioNTech and Moderna vaccines were 95.8 and 81 percent effective after three jabs respectively, while the viral vector-based AstraZeneca vaccine was 65.7 percent effective, Lo said.
The CDC study also found that Medigen and mRNA jabs had a longer efficacy period than the AstraZeneca vaccine, he said.
The research is the world’s first big data study on the efficacy of mRNA, protein-subunit and viral-vector COVID-19 vaccines that draw from real-world outcomes, he said, adding that the findings might boost the development of new protein-subunit vaccines, including Novavax.
The study vindicates the Medigen vaccine, which was unfairly criticized in the nation, Premier Chen Chien-jen (陳建仁) told an event marking the inking of a strategic alliance between Taiwan Bio-Manufacturing Corp (台灣生物醫藥製造) and US-based National Resilience Inc.
Taiwan handled its local outbreak with a conventional strategy, which proved successful in containing the virus’ spread and protecting economic growth, he said, adding that the nation has received international accolades for its accomplishment.
The COVID-19 pandemic showed that having pharmaceutical research capability without an industrial base to manufacture medicines at scale would not be enough to meet Taiwan’s needs, National Development Council Minister Kung Ming-hsin (龔明鑫) said.
The ability to mass produce medical drugs is crucial to public health as well as national security, but the nation’s NT$1 trillion (US$32.01 billion) biomedical industry has an undersized NT$700 billion to NT$800 billion manufacturing sector, he said.
Separately yesterday, Lo said that the CDC had delivered the last 156,000 Novavax XBB doses in its inventory to local governments.
The number of available Moderna and Novavax XBB vaccine doses stood at 459.2 million and 315,000 respectively, he said.
COVID-19 continues to circulate, with 52 percent of cases now being the JN.1 variant, Lo said, adding that XBB vaccines are about 50 percent effective against mild symptoms in adults.
The CDC urged the public to get inoculated ahead of the Lunar New Year holiday, which begins next week.
People older than 12 can get either type of the XXB vaccine, while children under that age can only receive Moderna’s version, it said.
Information about vaccination locations can be found online at: https://gov.tw/eU4.
Additional reporting by CNA
Taiwan is projected to lose a working-age population of about 6.67 million people in two waves of retirement in the coming years, as the nation confronts accelerating demographic decline and a shortage of younger workers to take their place, the Ministry of the Interior said. Taiwan experienced its largest baby boom between 1958 and 1966, when the population grew by 3.78 million, followed by a second surge of 2.89 million between 1976 and 1982, ministry data showed. In 2023, the first of those baby boom generations — those born in the late 1950s and early 1960s — began to enter retirement, triggering
ECONOMIC BOOST: Should the more than 23 million people eligible for the NT$10,000 handouts spend them the same way as in 2023, GDP could rise 0.5 percent, an official said Universal cash handouts of NT$10,000 (US$330) are to be disbursed late next month at the earliest — including to permanent residents and foreign residents married to Taiwanese — pending legislative approval, the Ministry of Finance said yesterday. The Executive Yuan yesterday approved the Special Act for Strengthening Economic, Social and National Security Resilience in Response to International Circumstances (因應國際情勢強化經濟社會及民生國安韌性特別條例). The NT$550 billion special budget includes NT$236 billion for the cash handouts, plus an additional NT$20 billion set aside as reserve funds, expected to be used to support industries. Handouts might begin one month after the bill is promulgated and would be completed within
The National Development Council (NDC) yesterday unveiled details of new regulations that ease restrictions on foreigners working or living in Taiwan, as part of a bid to attract skilled workers from abroad. The regulations, which could go into effect in the first quarter of next year, stem from amendments to the Act for the Recruitment and Employment of Foreign Professionals (外國專業人才延攬及僱用法) passed by lawmakers on Aug. 29. Students categorized as “overseas compatriots” would be allowed to stay and work in Taiwan in the two years after their graduation without obtaining additional permits, doing away with the evaluation process that is currently required,
RELEASED: Ko emerged from a courthouse before about 700 supporters, describing his year in custody as a period of ‘suffering’ and vowed to ‘not surrender’ Former Taiwan People’s Party (TPP) chairman Ko Wen-je (柯文哲) was released on NT$70 million (US$2.29 million) bail yesterday, bringing an end to his year-long incommunicado detention as he awaits trial on corruption charges. Under the conditions set by the Taipei District Court on Friday, Ko must remain at a registered address, wear a GPS-enabled ankle monitor and is prohibited from leaving the country. He is also barred from contacting codefendants or witnesses. After Ko’s wife, Peggy Chen (陳佩琪), posted bail, Ko was transported from the Taipei Detention Center to the Taipei District Court at 12:20pm, where he was fitted with the tracking
RSS